Dutch Pharma Stock News

Event overview and why ASM International is on investors’ radar ASM International (ENXTAM:ASM) has drawn investor attention after recent price moves, with the share price up around 2% over the past day but showing a 4% decline over the past month. See our latest analysis for ASM International. The recent 1-day share price return of 2.0% comes after a softer 30-day share price return of around a 4% decline. Longer term total shareholder returns of 49.8% over 1 year and 194.5% over 5 years...

On 19 March 2026, Flow Traders Ltd. launched a digital assets OTC offering that provides 24/7 proprietary, two-way liquidity for tokenized money-market funds, equities and commodities, including Franklin Templeton’s BENJI and Tether Gold, via its Digital Asset OTC platform. The move highlights how institutional investors are increasingly seeking round-the-clock access to tokenized instruments, using familiar OTC workflows, risk controls and connectivity across FIX, OMS/EMS platforms, ECNs...

Pharming Group (ENXTAM:PHARM) is back on investor radars after Japan’s Ministry of Health, Labour and Welfare approved Joenja for activated PI3K delta syndrome in patients aged 4 and older, including children 4 to 11. See our latest analysis for Pharming Group. The Joenja approval in Japan comes after a period where short term share price performance has been softer, with a 30 day share price return showing a decline of 1.21% and a year to date share price return showing a decline of 4.85%,...

On March 12, 2026, DSM-Firmenich AG announced a share repurchase program of up to €540 million, with €500 million earmarked for capital reduction and €40 million to satisfy share-based compensation, to be executed by a mandated bank and targeted for completion by the end of Q3 2026. This sizable buyback authorization signals the Board’s willingness to return cash to investors while tightening the share count, which can meaningfully influence ownership dilution from employee equity plans and...

Index removal puts Koninklijke Vopak (ENXTAM:VPK) in focus Koninklijke Vopak (ENXTAM:VPK) was removed from the FTSE All-World Index, a benchmark widely followed by institutional investors. This type of event can influence trading flows and how easily the stock appears on investor radars. See our latest analysis for Koninklijke Vopak. Despite the recent index removal and a 3.8% 7 day share price decline, Vopak’s 30 day share price return of 3.1% and 90 day gain of 21.8% sit alongside a 3 year...

This article examines whether Wolters Kluwer is attractively priced or still carries too much downside risk, by breaking down what the current share price might be implying about value. The stock last closed at €62.56, with returns of a 5.6% decline over 7 days, 0.3% over 30 days, a 28.9% decline year to date, and a 55.9% decline over 1 year. Many investors interpret this as a potential reset in expectations. Recent coverage has focused on how the share price performance contrasts with...

Event context and recent share performance Exor (ENXTAM:EXO) has drawn investor attention after a period of weaker share performance, with the stock showing a 1-day return decline of 1.85% and a past month return decline of 13.31%. See our latest analysis for Exor. At the current share price of €63.5, the stock’s weaker short term share price returns, including a 30 day share price decline of 13.31% and a year to date share price decline of 12.95%, align with a 1 year total shareholder return...

Ahold Delhaize USA CEO JJ Fleeman is set to step down in June 2026. The company has not yet named a successor for its U.S. operations. The transition affects one of the largest markets for Koninklijke Ahold Delhaize (ENXTAM:AD). Koninklijke Ahold Delhaize (ENXTAM:AD), trading at €40.53, sits at the center of a meaningful leadership change in its U.S. business. The company has seen returns of 16.2% year to date and 22.7% over the past year, with a 47.6% gain over three years and 102.0% over...

Wondering if ASML Holding at around €1,175 per share still makes sense for your portfolio, or if the price has run ahead of the fundamentals? The stock has had a mixed recent run, with a 1.8% decline over the past week and a 6.4% decline over the past month, while still showing a 19.2% gain year to date and a 75.8% return over the last year. Recent coverage has focused on ASML Holding's central role in supplying chipmaking equipment to major semiconductor producers and how that positioning...

SBM Offshore (ENXTAM:SBMO) has just moved into the Amsterdam AEX Index, shortly after its removal from the AMX. This shift often brings increased trading activity as index-tracking funds adjust their positions. See our latest analysis for SBM Offshore. The index change appears to have coincided with stronger momentum, with a 30-day share price return of 7.76% and a 90-day share price return of 35.75%, contributing to a 1-year total shareholder return of 75.83%. If this kind of index driven...

Akzo Nobel’s new bond issues and what they mean for shareholders Akzo Nobel (ENXTAM:AKZA) has launched two senior unsecured euro bond issues totaling €1.1b, offering 4% notes due 2031 and 4.625% notes due 2036. This is a funding move that directly affects its capital structure. See our latest analysis for Akzo Nobel. Despite the new bond issues, Akzo Nobel’s share price has been weak, with a 30-day share price return of 19.93% and a 1-year total shareholder return of 15.86%. This suggests...

Wolters Kluwer (ENXTAM:WKL) has been active on several fronts, from expanding AI powered tax research access for CPA Canada members to launching new cloud audit tools in Southeast Asia and extending key healthcare publishing partnerships. See our latest analysis for Wolters Kluwer. Despite the recent AI product launches, expanded healthcare publishing agreements and ongoing share buyback program, the stock’s 90 day share price return decline of 27.35% and 1 year total shareholder return...

Buyback announcement and what it could mean for DSM-Firmenich shares DSM-Firmenich (ENXTAM:DSFIR) has announced a share repurchase program of up to €540 million. Of this amount, €500 million is aimed at reducing issued capital and €40 million is reserved for share-based compensation commitments. See our latest analysis for DSM-Firmenich. At a share price of €58.12, DSM-Firmenich’s recent buyback announcement lands after a softer run, with a 30-day share price return of a 4% decline and a...

If you have been wondering whether Magnum Ice Cream at €12.88 is priced attractively or not, this article will walk through what that number could really mean for you as a shareholder. Over the short term, the share price has been soft, with a 4.6% decline over the last 7 days, a 4.4% decline over the last 30 days and a 3.1% decline year to date, which may change how investors think about both risk and opportunity. Recent coverage around consumer brands and listed food businesses has focused...

Philips (ENXTAM:PHIA) has launched the SpeechLive Health AI Assistant, a clinical documentation tool designed to help healthcare providers handle medical notes more efficiently. The company has also expanded its digital pathology portfolio with new cloud-enabled solutions developed in partnership with Amazon Web Services (AWS). These moves reflect Philips’ push to embed AI and cloud technology across clinical workflows in digital health and diagnostics. For investors following Philips, the...

Recent share performance and business snapshot Adyen (ENXTAM:ADYEN) has recently drawn investor attention after a period of weak share performance, with the stock showing negative returns over the past month, past 3 months, year to date, and past year. At a last close of €865.60 and a market value of about €27.3b, the payments platform reports annual revenue of €2,376.36m and net income of €1,062.53m, supported by annual revenue and net income growth of 15.6% and 15.5% respectively. See our...

AMG Critical Materials at a Glance After Recent Share Moves AMG Critical Materials (ENXTAM:AMG) has drawn fresh attention after a recent share price pullback, with the stock down about 11% over the past month but still showing a strong 1 year total return. See our latest analysis for AMG Critical Materials. The recent 11% monthly share price pullback, alongside a 5.6% one day share price decline and 8.9% seven day share price decline, contrasts with a strong 90.96% one year total shareholder...

Why ING Groep (ENXTAM:INGA) is on investors’ radar ING Groep (ENXTAM:INGA) has recently drawn fresh attention after a stretch of weaker share performance, with the stock showing a 2.7% decline over the past day and a one-month return decline of 9.2%. See our latest analysis for ING Groep. The recent 9.2% 1 month share price decline and 9.3% year to date share price return contrast with a 28.8% 1 year total shareholder return and very large 5 year total shareholder return. This suggests near...

Koninklijke Heijmans (ENXTAM:HEIJM) has drawn fresh attention after announcing an annual dividend of €2.37 per share, with an ex dividend date of May 4 and payment scheduled for May 12, 2026. See our latest analysis for Koninklijke Heijmans. The dividend announcement comes after a mixed recent run in the share price, with a 1 day share price return of 0.90%, a 30 day share price decline of 10.31%, a 90 day share price return of 19.70%, and a very large 5 year total shareholder return of...

ASML Holding stock reaction and recent performance With no single headline event driving ASML Holding (ENXTAM:ASML) today, attention turns to how the stock’s recent moves, earnings profile and geographic revenue mix may be shaping investor expectations. See our latest analysis for ASML Holding. Recent trading has been relatively muted, with a 90 day share price return of 33.42% and a 1 year total shareholder return of 78.52% pointing to strong momentum building over a longer stretch despite...

Wolters Kluwer (ENXTAM:WKL) has expanded its CCH iFirm Engagement cloud software to audit firms in Singapore and Malaysia, introducing what it describes as the first full cloud audit platform in these markets. The company has also integrated CME credit directly into its UpToDate Expert AI platform, allowing clinicians to earn education credits while using the tool. Both launches extend Wolters Kluwer's cloud and AI driven products into new geographies and deepen its role in everyday...

InPost (ENXTAM:INPST) has wrapped up FY 2025 with fourth quarter revenue of PLN 4.5b and basic EPS of PLN 0.12, as investors weigh these latest figures against a full year that produced trailing twelve month EPS of PLN 1.11 on revenue of PLN 14.7b. Over recent quarters, the company has seen revenue move from PLN 3.4b in Q4 2024 to PLN 4.5b in Q4 2025, while quarterly EPS shifted from PLN 0.81 to PLN 0.12. This sets up a mixed picture where growth in the top line contrasts with compressed...

Corbion (ENXTAM:CRBN) has just wrapped up FY 2025 with second half revenue of €621.8 million and basic EPS of €0.56, setting the tone for a year where trailing twelve month EPS reached €1.29 on revenue of €1.27 billion. Over recent periods, revenue has moved from €651.0 million in 2024 H2 to €645.6 million in 2025 H1 and €621.8 million in 2025 H2, while net income excluding extra items shifted from €23.2 million to €42.4 million and €32.4 million. This fed into a 63% earnings lift over the...

Avantium (ENXTAM:AVTX) has posted another loss for H1 2025, with revenue of €6.7 million, basic EPS of €1.08 loss, and net income loss of €9.4 million framing the latest set of numbers. Over recent halves the company has seen revenue move from €9.0 million in H1 2024 to €12.1 million in H2 2024, and EPS shift from a €1.75 loss in H1 2024 to a €1.69 loss in H2 2024, while trailing twelve month EPS sits at a €2.86 loss on €18.8 million of revenue. For investors, the key question now is whether...